Matthijs Moerland Selected Research

Sleepiness

1/2021	Proof of pharmacology of Org 48775-0, a p38 MAP kinase inhibitor, in healthy volunteers.
8/2012	Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthijs Moerland Research Topics

Disease

9	Inflammation (Inflammations) 05/2024 - 07/2008
8	Atherosclerosis 10/2009 - 09/2006
7	Erythema 01/2024 - 11/2018
5	Necrosis 05/2024 - 10/2013
4	Blister (Bulla) 05/2024 - 01/2022
4	Thrombosis (Thrombus) 12/2022 - 02/2003
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2022
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2020
2	Body Weight (Weight, Body) 01/2023 - 01/2022
2	Endotoxemia 09/2022 - 01/2018
2	Headache (Headaches) 01/2022 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Sleepiness 01/2021 - 08/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 10/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 04/2016
2	Injection Site Reaction 01/2016 - 12/2015
2	Atherosclerotic Plaque (Atheroma) 12/2011 - 03/2010
2	Rupture 12/2011 - 03/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Intestinal Failure 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Hyperemia 01/2023
1	Movement Disorders (Movement Disorder) 01/2023
1	Short Bowel Syndrome 01/2023
1	Sepsis (Septicemia) 12/2022
1	Infections 09/2022
1	Leukopenia 01/2022
1	Dysbiosis 01/2022
1	Syncope (Fainting) 01/2022
1	Asthenia 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Cystinosis 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Nasopharyngitis 01/2021
1	Phlebitis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Thrombophilia 08/2020
1	Hemorrhage 07/2020

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 05/2024 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
5	Imiquimod (Aldara)FDA LinkGeneric 05/2024 - 11/2018
5	Lipoproteins (Lipoprotein)IBA 12/2016 - 09/2006
4	Interleukin-8 (Interleukin 8)IBA 05/2024 - 01/2022
4	Phospholipid Transfer ProteinsIBA 10/2009 - 09/2006
3	Interleukin-6 (Interleukin 6)IBA 05/2024 - 12/2022
3	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 01/2022
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 01/2021
3	LDL Receptors (LDL Receptor)IBA 07/2008 - 12/2007
2	InterferonsIBA 05/2024 - 01/2022
2	Interleukin-10 (Interleukin 10)IBA 05/2024 - 01/2022
2	InterleukinsIBA 05/2024 - 01/2022
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2023 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Antimicrobial PeptidesIBA 01/2022 - 01/2020
2	OmigananIBA 01/2022 - 01/2020
2	Huntingtin ProteinIBA 01/2021 - 01/2020
2	VaccinesIBA 10/2020 - 01/2020
2	MDCO-216IBA 12/2016 - 04/2016
2	LipidsIBA 12/2016 - 09/2006
2	CholesterolIBA 04/2016 - 06/2009
2	HDL LipoproteinsIBA 04/2016 - 09/2006
2	OligonucleotidesIBA 01/2016 - 10/2013
2	CreatinineIBA 12/2015 - 10/2013
1	zabedosertibIBA 01/2024
1	Glucagon (Glukagon)FDA Link 01/2023
1	Glucosylceramides (Glucocerebrosides)IBA 01/2023
1	GlycosphingolipidsIBA 01/2023
1	HydrogenIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	CDw17 antigen (lactosylceramide)IBA 01/2023
1	apraglutideIBA 01/2023
1	Toll-Like Receptor 7IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	C-Reactive ProteinIBA 12/2022
1	Thromboplastin (Tissue Factor)IBA 12/2022
1	Toll-Like Receptor 4IBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	EnzymesIBA 01/2022
1	SynucleinsIBA 01/2022
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2022
1	Immunoglobulin M (IgM)IBA 01/2021
1	Delayed-Action PreparationsIBA 01/2021
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2021
1	Cysteamine (Mercaptamine)FDA Link 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	E-SelectinIBA 08/2020
1	Erythropoietin FDA Link 08/2020
1	SugammadexIBA 07/2020

Therapy/Procedure

8	Therapeutics 01/2023 - 10/2013
2	Lasers (Laser) 01/2024 - 01/2020
1	Immunomodulation 05/2024
1	Oral Administration 01/2023
1	Topical Administration 01/2022
1	Catheters 01/2021